Associated Papers
Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose Osimertinib.
Zwierenga F et al.
Targeted Oncology, 2025
Mutation spectrum of retinoblastoma patients in Vietnam.
Linh DNH et al.
Molecular Genetics & Genomic Medicine, 2023
MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression.
Farnsworth DA et al.
Npj Precision Oncology, 2022
36418460 (PubMed )
Supplement: 41698_2022_328_MOESM3_ESM.xlsx › SupplementaryTable_1
Germline RB1 Mutation in Retinoblastoma Patients: Detection Methods and Implication in Tumor Focality.
Rojanaporn D et al.
Translational Vision Science & Technology, 2022
36173648 (PubMed )
Supplement: tvst-11-9-30_s001.xlsx › n_1303
Mosaicism in Tumor Suppressor Gene Syndromes: Prevalence, Diagnostic Strategies, and Transmission Risk.
Chen JL et al.
Annual Review of Genomics and Human Genetics, 2022
36044908 (PubMed )
Supplement: gg23-giannikou_suptable1.xlsx › RB1
NGS Analysis Confirms Common TP53 and RB1 Mutations, and Suggests MYC Amplification in Ocular Adnexal Sebaceous Carcinomas.
Peterson C et al.
International Journal of Molecular Sciences, 2021
Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer.
Bhateja P et al.
Cancer Medicine, 2019
[Molecular diagnosis of retinoblastoma. First experience in Russia].
Babenko OV et al.
Vestnik Oftalmologii, 0
[Spectrum and frequencies of RB1 gene structural defects in retinoblastoma].
Babenko OV et al.
Molekuliarnaia Biologiia, 0
[RB1 and CDKN2A functional defects resulting in retinoblastoma].
Babenko OV et al.
Molekuliarnaia Biologiia, 0
Select a paper to view details